Aspirin Eugenol Ester Alleviates Fatty Liver Hemorrhagic Syndrome in Laying Hens by Modulating AMPK/mTOR-Mediated Autophagy
Biomolecules · 16.11.2026 · 16 (11) · 1666
DOI: 10.3390/biom16111666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 16.11.2026. Verfasst von Wenbo Ge und 10 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Gansu Province, Lanzhou Youth Science and Technology Talent Innovation Project.
Abstract (Originalsprache)
Background
Fatty liver hemorrhagic syndrome (FLHS) is a nutritional-metabolic disorder of laying hens with pathological features analogous to human non-alcoholic fatty liver disease (NAFLD). Aspirin eugenol ester (AEE) has lipid-lowering, anti-inflammatory, and antioxidant activities; however, its protective effects and the underlying molecular mechanisms against FLHS remain unclear.
Methods
In this study, we established an in vivo FLHS model in laying hens using a high-energy low-protein diet and an in vitro steatosis model induced by free fatty acids in LMH cells, to explore the hepatoprotective function of AEE.
Results
AEE alleviated hepatic lipid accumulation and histopathological lesions, and decreased lipid levels in serum and liver tissue. AEE downregulated the expression of key lipogenic enzymes and upregulated the expression of genes responsible for fatty acid β-oxidation. RNA-seq analysis indicated that the AMPK signaling pathway and autophagy were tightly linked to the hepatoprotective effects of AEE. Treatment with the autophagy activator rapamycin recapitulated the protective effects of AEE, whereas the autophagy inhibitor chloroquine abrogated these beneficial effects. Furthermore, the AMPK inhibitor dorsomorphin partially reversed AEE-mediated liver protection, while the AMPK activator AICAR reproduced the protective effects of AEE.
Conclusions
These results indicate that AEE alleviates FLHS in laying hens at least partly through modulation of fatty acid metabolism, likely associated with AMPK/mTOR-mediated autophagy. This work provides mechanistic insights for AEE as a candidate agent for preventing diet-triggered hepatic steatosis.
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Gansu Province
- Lanzhou Youth Science and Technology Talent Innovation Project
- Central Public-interest Scientific Institution Basal Research Fund
Zitieren
APA
Ge, W., Yan, K., Yang, Y., Liu, X., Xu, X., Bai, L., Qin, Z., Li, Z., Li, S., Lu, D., & Li, J. (2026). Aspirin Eugenol Ester Alleviates Fatty Liver Hemorrhagic Syndrome in Laying Hens by Modulating AMPK/mTOR-Mediated Autophagy. Biomolecules, 16(11), 1666. https://doi.org/10.3390/biom16111666
Vancouver
Ge W, Yan K, Yang Y, Liu X, Xu X, Bai L, et al. Aspirin Eugenol Ester Alleviates Fatty Liver Hemorrhagic Syndrome in Laying Hens by Modulating AMPK/mTOR-Mediated Autophagy. Biomolecules. 2026;16(11):1666. doi:10.3390/biom16111666
BibTeX
@article{Ge2026,
author = {Ge, Wenbo and Yan, Kai and Yang, Yajun and Liu, Xiwang and Xu, Xiao and Bai, Lixia and Qin, Zhe and Li, Zhun and Li, Shihong and Lu, Di and Li, Jianyong},
title = {Aspirin Eugenol Ester Alleviates Fatty Liver Hemorrhagic Syndrome in Laying Hens by Modulating AMPK/mTOR-Mediated Autophagy},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {11},
pages = {1666},
doi = {10.3390/biom16111666}
}
EUVIMED